Ceraxon solution 500mg 4ml №5

/ Ceraxon

Active ingredient and dosage form

Ceraxon - solution for intravenous and intramuscular administration:

4 ml contain citicoline sodium 522.5 and 1045 mg, excipients: 1M hydrochloric acid or 1M sodium hydroxide to a pH of 6.7-7.1; water for injection - up to 4 ml; in the ampoules of neutral glass 4 ml each; in the blister pack of 3 ampoules; in a carton pack 1 pack or in a blister pack of 5 ampoules; in a cardboard bundle 1 or 2 packs;

Ceraxon - solution for oral administration 100 mg / ml:

1 fl. contains citicoline sodium 10.45 g, excipients: sorbitol; glycerol; methyl parahydroxybenzoate; propyl parahydroxybenzoate; glycerol formal; sodium citrate dihydrate; sodium saccharinate; crimson dye (Ponso 4-R); strawberry flavoring (strawberry essence 1487-S-Lucta); potassium sorbate; citric acid 50% solution; purified water - up to 100 ml;

in vials of clear colorless glass of 30 ml.

Mechanism of action

Ceraxon has a nootropic effect.

Indications and usage

Acute ischemic stroke;

recovery period of ischemic and hemorrhagic strokes;

traumatic brain injury, acute and recovery period;

cognitive impairment in degenerative and vascular diseases of the brain.

Contraindications

Hypersensitivity to any of the components of Cerakson;

patients with vagotonia (predominance of the parasympathetic component of the autonomic nervous system);

children under 18 years (due to lack of data).

Pregnancy and Breastfeeding

Controlled studies during pregnancy were not conducted. Although there was no evidence of a risk to the fetus when using the drug, during pregnancy the drug is prescribed only if the expected benefit outweighs the potential risk.

When prescribing Cerakson during lactation, women should stop breastfeeding, since there are no data on the allocation of citicoline with breast milk.

Adverse reactions

Allergic reactions (rash, itchy skin, anaphylactic shock), insomnia, headache, dizziness, agitation, tremor, numbness in paralyzed limbs, nausea, loss of appetite, changes in liver enzymes, fever.In some cases, Cerakson can stimulate the parasympathetic system, as well as provide a short-term hypotensive effect.

Dosage and administration

Solution for intravenous and intramuscular administration Ceraxon is administered intravenously, in the form of a slow intravenous injection (within 5 min) or drip intravenous infusion (40-60 drops per minute) for stroke and TBI in the acute period - 1000 2000 mg daily, depending on the severity of the disease for 3-7 days with the subsequent transition to the i / m administration or ingestion. In / in and oral route of administration is preferable to the / m.

V / m: 1-2 injections per day. When i / m injection should be repeated administration of the drug in the same place.

Solution for oral administration Tserakson taken orally, 200-300 mg (2-3 ml) 3 times a day. (The drug is prescribed using a dosing syringe).

Storage conditions

In the dark place at a temperature of 2-25 ° C. Shelf life - 3 years.